Financials data is unavailable for this security.
View more
Year on year MatsukiyoCocokara & Co grew revenues 7.49% from 951.25bn to 1.02tn while net income improved 29.10% from 40.55bn to 52.35bn.
| Gross margin | 34.85% |
|---|---|
| Net profit margin | 4.98% |
| Operating margin | 7.03% |
| Return on assets | 7.30% |
|---|---|
| Return on equity | 10.26% |
| Return on investment | 9.56% |
More ▼
Cash flow in JPYView more
In 2024, MatsukiyoCocokara & Co increased its cash reserves by 23.62%, or 22.50bn. The company earned 63.51bn from its operations for a Cash Flow Margin of 6.21%. In addition the company used 22.76bn on investing activities and also paid 18.27bn in financing cash flows.
| Cash flow per share | 180.37 |
|---|---|
| Price/Cash flow per share | 11.22 |
| Book value per share | 1,240.24 |
|---|---|
| Tangible book value per share | 916.74 |
More ▼
Balance sheet in JPYView more
| Current ratio | 2.02 |
|---|---|
| Quick ratio | 1.21 |
| Total debt/total equity | 0.0389 |
|---|---|
| Total debt/total capital | 0.0374 |
More ▼
Growth rates in JPY
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 57.14% and 30.51%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Retail (Drugs) industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
| Div yield(5 year avg) | 1.42% |
|---|---|
| Div growth rate (5 year) | 11.10% |
| Payout ratio (TTM) | 32.71% |
| EPS growth(5 years) | 9.45 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | 8.60 |
More ▼
